Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Jul;74(1):109–114. doi: 10.1038/bjc.1996.323

Expression of NM23 in human melanoma progression and metastasis.

D J Easty 1, K Maung 1, I Lascu 1, M Véron 1, M E Fallowfield 1, I R Hart 1, D C Bennett 1
PMCID: PMC2074602  PMID: 8679442

Abstract

NM23 is a putative metastasis-suppressor gene for some human cancers. Here we have studied NM23 expression during melanoma progression using Northern blotting and immunocytochemistry. There was no significant difference in the average amounts of NM23 mRNA between cell lines derived from metastatic and primary melanomas. The level of NM23 mRNA was also determined for three pairs of poorly metastatic parental (P) and their highly metastatic variant (M) cell lines; the ratios for M/P were 1.2, 0.98 and 0.80. Next we used immunocytochemistry to study NM23 protein in normal skin, benign naevi and primary and metastatic melanomas. Melanocytes in all normal skin and benign samples were positive for NM23; however most primary melanomas (7/11) were not stained by the antibody. All metastatic melanoma samples (5/5) were positively stained. Findings were similar with an antiserum reactive with both forms of NM23 (H1 and H2), and with an antibody specific for NM23-H1. No relationship was apparent between NM23 immunoreactivity in primary tumours and their aggressiveness or prognosis. Hence, in contrast to the situation described for murine melanoma, the amount of NM23 mRNA or protein in human melanoma did not correlate inversely with metastasis.

Full text

PDF
109

Images in this article

111Figure 1
on p.111
111Figure 2
on p.111
112Figure 3
on p.112
112Figure 4
on p.112
112Figure 5
on p.112

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertheau P., De La Rosa A., Steeg P. S., Merino M. J. NM23 protein in neoplastic and nonneoplastic thyroid tissues. Am J Pathol. 1994 Jul;145(1):26–32. [PMC free article] [PubMed] [Google Scholar]
  2. Bevilacqua G., Sobel M. E., Liotta L. A., Steeg P. S. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res. 1989 Sep 15;49(18):5185–5190. [PubMed] [Google Scholar]
  3. Chang C. L., Zhu X. X., Thoraval D. H., Ungar D., Rawwas J., Hora N., Strahler J. R., Hanash S. M., Radany E. Nm23-H1 mutation in neuroblastoma. Nature. 1994 Aug 4;370(6488):335–336. doi: 10.1038/370335a0. [DOI] [PubMed] [Google Scholar]
  4. Clark W. H., Jr, Elder D. E., Guerry D., 4th, Braitman L. E., Trock B. J., Schultz D., Synnestvedt M., Halpern A. C. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989 Dec 20;81(24):1893–1904. doi: 10.1093/jnci/81.24.1893. [DOI] [PubMed] [Google Scholar]
  5. Dorudi S., Hart I. R. Mechanisms underlying invasion and metastasis. Curr Opin Oncol. 1993 Jan;5(1):130–135. [PubMed] [Google Scholar]
  6. Easty D. J., Ganz S. E., Farr C. J., Lai C., Herlyn M., Bennett D. C. Novel and known protein tyrosine kinases and their abnormal expression in human melanoma. J Invest Dermatol. 1993 Nov;101(5):679–684. doi: 10.1111/1523-1747.ep12371675. [DOI] [PubMed] [Google Scholar]
  7. Easty D. J., Guthrie B. A., Maung K., Farr C. J., Lindberg R. A., Toso R. J., Herlyn M., Bennett D. C. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. Cancer Res. 1995 Jun 15;55(12):2528–2532. [PubMed] [Google Scholar]
  8. Easty D. J., Herlyn M., Bennett D. C. Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis. Int J Cancer. 1995 Jan 3;60(1):129–136. doi: 10.1002/ijc.2910600119. [DOI] [PubMed] [Google Scholar]
  9. Feinberg A. P., Vogelstein B. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem. 1984 Feb;137(1):266–267. doi: 10.1016/0003-2697(84)90381-6. [DOI] [PubMed] [Google Scholar]
  10. Fidler I. J., Radinsky R. Genetic control of cancer metastasis. J Natl Cancer Inst. 1990 Feb 7;82(3):166–168. doi: 10.1093/jnci/82.3.166. [DOI] [PubMed] [Google Scholar]
  11. Flørenes V. A., Aamdal S., Myklebost O., Maelandsmo G. M., Bruland O. S., Fodstad O. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res. 1992 Nov 1;52(21):6088–6091. [PubMed] [Google Scholar]
  12. Gilles A. M., Presecan E., Vonica A., Lascu I. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem. 1991 May 15;266(14):8784–8789. [PubMed] [Google Scholar]
  13. Hailat N., Keim D. R., Melhem R. F., Zhu X. X., Eckerskorn C., Brodeur G. M., Reynolds C. P., Seeger R. C., Lottspeich F., Strahler J. R. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest. 1991 Jul;88(1):341–345. doi: 10.1172/JCI115299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hart I. R., Easty D. Identification of genes controlling metastatic behaviour. Br J Cancer. 1991 Jan;63(1):9–12. doi: 10.1038/bjc.1991.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hennessy C., Henry J. A., May F. E., Westley B. R., Angus B., Lennard T. W. Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst. 1991 Feb 20;83(4):281–285. doi: 10.1093/jnci/83.4.281. [DOI] [PubMed] [Google Scholar]
  16. Herlyn D., Iliopoulos D., Jensen P. J., Parmiter A., Baird J., Hotta H., Adachi K., Ross A. H., Jambrosic J., Koprowski H. In vitro properties of human melanoma cells metastatic in nude mice. Cancer Res. 1990 Apr 15;50(8):2296–2302. [PubMed] [Google Scholar]
  17. Higashiyama M., Doi O., Yokouchi H., Kodama K., Nakamori S., Tateishi R., Kimura N. Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: lack of prognostic value. Br J Cancer. 1992 Sep;66(3):533–536. doi: 10.1038/bjc.1992.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hirayama R., Sawai S., Takagi Y., Mishima Y., Kimura N., Shimada N., Esaki Y., Kurashima C., Utsuyama M., Hirokawa K. Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J Natl Cancer Inst. 1991 Sep 4;83(17):1249–1250. doi: 10.1093/jnci/83.17.1249. [DOI] [PubMed] [Google Scholar]
  19. Lacombe M. L., Sastre-Garau X., Lascu I., Vonica A., Wallet V., Thiery J. P., Véron M. Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours. Eur J Cancer. 1991;27(10):1302–1307. doi: 10.1016/0277-5379(91)90101-i. [DOI] [PubMed] [Google Scholar]
  20. Leone A., Flatow U., King C. R., Sandeen M. A., Margulies I. M., Liotta L. A., Steeg P. S. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell. 1991 Apr 5;65(1):25–35. doi: 10.1016/0092-8674(91)90404-m. [DOI] [PubMed] [Google Scholar]
  21. Leone A., Seeger R. C., Hong C. M., Hu Y. Y., Arboleda M. J., Brodeur G. M., Stram D., Slamon D. J., Steeg P. S. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene. 1993 Apr;8(4):855–865. [PubMed] [Google Scholar]
  22. Levine A. J. The tumor suppressor genes. Annu Rev Biochem. 1993;62:623–651. doi: 10.1146/annurev.bi.62.070193.003203. [DOI] [PubMed] [Google Scholar]
  23. Liotta L. A., Steeg P. S., Stetler-Stevenson W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 1991 Jan 25;64(2):327–336. doi: 10.1016/0092-8674(91)90642-c. [DOI] [PubMed] [Google Scholar]
  24. MacDonald N. J., De la Rosa A., Benedict M. A., Freije J. M., Krutsch H., Steeg P. S. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem. 1993 Dec 5;268(34):25780–25789. [PubMed] [Google Scholar]
  25. MacDonald N. J., Steeg P. S. Molecular basis of tumour metastasis. Cancer Surv. 1993;16:175–199. [PubMed] [Google Scholar]
  26. Morse H. G., Moore G. E. Cytogenetic homogeneity in eight independent sites in a case of malignant melanoma. Cancer Genet Cytogenet. 1993 Sep;69(2):108–112. doi: 10.1016/0165-4608(93)90083-x. [DOI] [PubMed] [Google Scholar]
  27. Okabe-Kado J., Kasukabe T., Honma Y., Hayashi M., Henzel W. J., Hozumi M. Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase. Biochem Biophys Res Commun. 1992 Feb 14;182(3):987–994. doi: 10.1016/0006-291x(92)91829-f. [DOI] [PubMed] [Google Scholar]
  28. Ormerod E. J., Everett C. A., Hart I. R. Enhanced experimental metastatic capacity of a human tumor line following treatment with 5-azacytidine. Cancer Res. 1986 Feb;46(2):884–890. [PubMed] [Google Scholar]
  29. Parker C., Sherbet G. V. Modulators of intracellular Ca2+ and the calmodulin inhibitor W-7 alter the expression of metastasis-associated genes MTS1 and NM23 in metastatic variants of the B16 murine melanoma. Melanoma Res. 1992 Dec;2(5-6):337–343. doi: 10.1097/00008390-199212000-00007. [DOI] [PubMed] [Google Scholar]
  30. Postel E. H., Berberich S. J., Flint S. J., Ferrone C. A. Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science. 1993 Jul 23;261(5120):478–480. doi: 10.1126/science.8392752. [DOI] [PubMed] [Google Scholar]
  31. Radinsky R., Weisberg H. Z., Staroselsky A. N., Fidler I. J. Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms. Cancer Res. 1992 Oct 15;52(20):5808–5814. [PubMed] [Google Scholar]
  32. Sastre-Garau X., Lacombe M. L., Jouve M., Véron M., Magdelénat H. Nucleoside diphosphate kinase/NM23 expression in breast cancer: lack of correlation with lymph-node metastasis. Int J Cancer. 1992 Feb 20;50(4):533–538. doi: 10.1002/ijc.2910500406. [DOI] [PubMed] [Google Scholar]
  33. Sawan A., Lascu I., Veron M., Anderson J. J., Wright C., Horne C. H., Angus B. NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study. J Pathol. 1994 Jan;172(1):27–34. doi: 10.1002/path.1711720107. [DOI] [PubMed] [Google Scholar]
  34. Steeg P. S., Bevilacqua G., Kopper L., Thorgeirsson U. P., Talmadge J. E., Liotta L. A., Sobel M. E. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988 Apr 6;80(3):200–204. doi: 10.1093/jnci/80.3.200. [DOI] [PubMed] [Google Scholar]
  35. Tokunaga Y., Urano T., Furukawa K., Kondo H., Kanematsu T., Shiku H. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int J Cancer. 1993 Aug 19;55(1):66–71. doi: 10.1002/ijc.2910550113. [DOI] [PubMed] [Google Scholar]
  36. Warburton M. J., Mitchell D., Ormerod E. J., Rudland P. Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating, and involuting rat mammary gland. J Histochem Cytochem. 1982 Jul;30(7):667–676. doi: 10.1177/30.7.6179984. [DOI] [PubMed] [Google Scholar]
  37. Xerri L., Grob J. J., Battyani Z., Gouvernet J., Hassoun J., Bonerandi J. J. NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival. Br J Cancer. 1994 Dec;70(6):1224–1228. doi: 10.1038/bjc.1994.477. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES